PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
33575163-13	2021	Compared with the LPS group, APS pretreatment could inhibit the expression of inflammatory factors including TNF-alpha, IL-1 beta, IL-6, and IL-8 (all P < 0.05), reducing the number of apoptotic cells (P < 0.05), suppressing the expression of caspase-3, caspase-9, and Bax, but upregulating the expression levels of Bcl-2.	aps	29-32	interleukin 6	Mus musculus	131-135	
30590152-6	2019	The secretion and gene expression of NO/iNOS, IL-6 and TNF-alpha in APS-induced macrophage cell were significantly enhanced.	aps	68-71	interleukin 6	Mus musculus	46-50	
30590152-9	2019	Therefore, we demonstrated that APS could improve the immune functions of RAW 264.7 macrophages cells by promoting the cell viability and increasing secretion and gene expressions of NO/iNOS, IL-6 and TNF-alpha through the MAPK and NF-kappaB signaling pathways.	aps	32-35	interleukin 6	Mus musculus	192-196	
34289209-6	2021	Consistent with the changes in MDSCs, the serum level of IL-6, IL-1beta was the lowest in the APS group.	aps	94-97	interleukin 6	Mus musculus	57-61